The Venture Codex Logo

The Venture Codex

TailorMed

Moses Yehuda & Noah 13, Building A, 4th floor, Tel Aviv, 6473921, Israel

Overview

TailorMed provides a web-based financial assistance platform that matches patients to relevant opportunities across roughly 6,000 resources and streamlines ongoing program management. The company operates what it describes as the nation’s largest network of patients, providers, pharmacies, partners, and life science companies focused on affordability. Its platform is deployed across more than 1,000 sites of care, including Providence Health, UnityPoint Health, Yale-New Haven Health, and Advocate Aurora Health. TailorMed’s tools enable healthcare organizations to proactively identify, match, and enroll patients in financial assistance programs at scale, simplifying an operationally complex process. The product aims to improve the patient financial experience while reducing the cost of care delivery and increasing revenues for provider organizations. TailorMed is expanding and strengthening its network with support from strategic health-system investors. TailorMed offers a best-in-class financial navigation platform that automates identification of financially at-risk patients and matches/enrolls them in resources such as co-pay assistance, replacement drug programs, government subsidies, foundations, and programs addressing living expenses and social determinants of health. The platform is used by health systems, clinics, physician practices, specialty clinics and pharmacies nationwide and aims to reduce out-of-pocket responsibility and avoidance of care. For provider organizations, TailorMed shifts financial assistance from reactive downstream collections to proactive support at the point of care. The company says its technology supports patients across all medical conditions and treatment types. TailorMed will use the new funding to further expand its reach across health care and develop innovative financial solutions.

Total raised
$25M
Funding rounds
2
Latest round
Equity
Latest activity
Sep 2021

Industries

  • Medical Device
Visit website

Recent funding

  1. Equity

    Sep 2021

    $25M

Team